AVALO THERAPEUTICS INC (AVTX) Stock Income Statement
NASDAQ:AVTX • US05338F3064
17.64 USD
+0.79 (+4.66%)
At close: Feb 26, 2026
17.64 USD
0 (0%)
After Hours: 2/26/2026, 8:11:22 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 192.00K | 441.00K | 1.92M | 18.05M | 5.40M | |||
| Cost Of Goods | N/A | -366.00K | 1.28M | 3.43M | 1.49M | |||
| Gross Profit | N/A | 807.00K | 640.00K | 14.62M | 3.91M | |||
| Operating Expenses | 66.61M | 41.68M | 24.08M | 52.06M | 86.04M | |||
| Research and Development | N/A | 24.44M | 13.78M | 31.31M | 59.84M | |||
| Selling, General, and Administrative Expenses | 21.60M | 17.24M | 10.30M | 20.71M | 24.66M | |||
| Operating Income | -66.51M | -40.87M | -23.44M | -37.44M | -82.13M | |||
| Interest Income/Expense | N/A | 387.00K | -4.14M | -4.17M | -2.39M | |||
| Other Income/Expense | -26.47M | 33.11M | -42.00K | -20.00K | -20.00K | |||
| Non Recurring Items | N/A | -27.64M | -3.91M | N/A | 0.00 | |||
| Income Before Taxes | -99.84M | -35.02M | -31.53M | -41.63M | -84.55M | |||
| Income Tax | 155.00K | 114.00K | 14.00K | 30.00K | -200.00K | |||
| Net Income | -99.79M | -35.13M | -31.54M | -41.66M | -84.38M | |||
| EBITDA | -66.11M | -40.70M | -23.29M | -37.27M | -80.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.72 | -7.94 | -113.58 | -4.43 | -10.13 | |||
| Non GAAP EPS | -13.31 | -164.27 | -488.22 | -1.08K | -2.39K | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 182.99% | 33.26% | 81.00% | 72.41% | |||
| Profit Margin | -51972.40% | -7965.76% | -1639.50% | -230.80% | -1562.59% | |||
| Operating Profit Margin | -34640.10% | -9267.80% | -1218.50% | -207.42% | -1520.93% | |||
All data in USD